Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
grail
4
×
life sciences
national
4
×
national blog main
4
×
national top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
cancer
celgene
clinical study
merger
multiple myeloma
novartis
pfizer
scott gottlieb
trial
acquisition
actavalon
What
bio
roundup
abbvie’s
airport
annual
apocalypse
ask
barbecuing
beds
blood
broader
camping
cancer
cardiologist
celgene
center
check
cholesterol
company
conference
congrats
day
days
detect
developing
effect
fallout
files
firms
flop
gone
grail
hit
home
honored
icer’s
intended
investors
ipo
isn't
Language
unset
Current search:
grail
×
national
×
" national blog main "
×
@xconomy.com
3 years ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com
4 years ago
Bio Roundup: Nobel Prizes, Placebo Effect Rises, ICER’s Fire & More
@xconomy.com
4 years ago
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More